Related Experiment Video

Updated: Jun 5, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

[Parameters of platelets activation and myeloperoxidase concentration as markers of coronary disease]

Joanna Pawlus1, Małgorzata Rusak, Joanna Chociej-Stypułkowska

  • 1Uniwersytet Medyczny w Białymstoku, Zakład Diagnostyki Hematologicznej.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|January 7, 2011
PubMed

Insights

Large platelets and neutrophils contribute to ischemic heart disease by promoting thrombus formation and plaque instability. Myeloperoxidase released by neutrophils further exacerbates atherosclerotic complications.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Pathophysiology

Context:

  • Ischemic heart disease (IHD) pathogenesis involves atherosclerosis and its complications.
  • Platelets play a crucial role in initiating atherosclerotic lesions and thrombus formation.
  • Neutrophils (PMNs) and their released myeloperoxidase (MPO) are increasingly implicated in myocardial injury.

Purpose:

  • To elucidate the roles of platelet size and neutrophil activation in IHD.
  • To understand the mechanisms by which PMNs and MPO contribute to atherosclerotic plaque destabilization and myocardial damage.

Summary:

  • Larger platelets exhibit higher enzymatic activity and greater thrombotic potential compared to smaller platelets.
  • Neutrophil activation leads to the release of myeloperoxidase (MPO) into coronary circulation.
  • MPO promotes atherosclerotic plaque rupture and impairs crucial vascular functions, contributing to myocardial cell injury.

Impact:

  • Highlights the significance of platelet size as a thrombotic risk factor in IHD.
  • Identifies neutrophil-derived MPO as a key mediator in the progression and destabilization of atherosclerotic plaques.
  • Provides insights into potential therapeutic targets for managing ischemic heart disease by modulating platelet and neutrophil activity.

More Related Videos

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...